Careers

Acceleron Pharma takes pride in its energetic spirit of collaboration. We have a unique culture and are looking to expand our team. Join the success!
VIEW LATEST POSTINGS >

Products

Our discovery platform is an exceptionally rich source of novel protein therapies to treat patients with life-threatening and debilitating conditions.

• ACE-011 for Anemia
• ACE-031 for Neuromuscular Disease
• ACE-041 for Advanced Cancer

Latest News

08/19/2010
Acceleron Receives FDA Orphan Designation for ACE-031 for Treatment of Duchenne Muscular Dystrophy
READ MORE

08/04/2010
Acceleron Receives FDA Fast Track Designation for ACE-031 for Duchenne Muscular Dystrophy
READ MORE

05/05/2010
Acceleron Initiates Phase 2 Clinical Trial with ACE-031 in Patients with Duchenne Muscular Dystrophy
READ MORE

03/23/2010
Acceleron and Collaborators Publish Two Papers on ACE-041, a Novel Angiogenesis Inhibitor
READ MORE